We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
87.75%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$768M
AUM Growth
+$22.8M
(+3.1%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,093
New
800
Increased
114
Reduced
121
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.93M |
| 2 |
CACI
CACI
|
+$5.05M |
| 3 |
CELG
Celgene Corp
CELG
|
+$4.9M |
| 4 |
Yelp
YELP
|
+$4.72M |
| 5 |
Norfolk Southern
NSC
|
+$4.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradata
TDC
|
+$6.01M |
| 2 |
Gilead Sciences
GILD
|
+$5M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.91M |
| 4 |
Copa Holdings
CPA
|
+$4.6M |
| 5 |
Lowe's Companies
LOW
|
+$4.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.19% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.55% |
| 4 | Industrials | 12.49% |
| 5 | Consumer Discretionary | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBL
551
DELISTED
Noble Energy, Inc.
NBL
| $25K | ﹤0.01% |
+811
| New | +$24.4K |
|
552
Broadridge
BR
$19B
| $24K | ﹤0.01% |
+217
| New | +$21.5K |
|
553
Quest Diagnostics
DGX
$26.3B
| $24K | ﹤0.01% |
+240
| New | +$24.6K |
|
554
Genpact
G
$5.76B
| $24K | ﹤0.01% |
+750
| New | +$24.4K |
|
555
Keurig Dr Pepper
KDP
$40.8B
| $24K | ﹤0.01% |
+200
| New | +$22.2K |
|
556
PVH
PVH
$4.04B
| $24K | ﹤0.01% |
+158
| New | +$23K |
|
557
TSMC
TSM
$2.18T
| $24K | ﹤0.01% |
+547
| New | +$23.8K |
|
|
WCC
558
WESCO International
WCC
$17.7B
| $24K | ﹤0.01% |
+392
| New | +$25.3K |
|
559
Brunswick
BC
$5.28B
| $23K | ﹤0.01% |
+383
| New | +$22.6K |
|
560
BHP
BHP
$230B
| $23K | ﹤0.01% |
+592
| New | +$24.9K |
|
561
Dick's Sporting Goods
DKS
$18.7B
| $23K | ﹤0.01% |
+645
| New | +$21K |
|
562
EnerSys
ENS
$6.99B
| $23K | ﹤0.01% |
+330
| New | +$23.5K |
|
563
Fossil Group
FOSL
$318M
| $23K | ﹤0.01% |
+1,818
| New | +$20.1K |
|
564
O-I Glass
OI
$1.08B
| $23K | ﹤0.01% |
1,069
-153,790
| -99% | -$3.41M |
|
565
PTC
PTC
$16B
| $23K | ﹤0.01% |
+298
| New | +$21.7K |
|
566
Rio Tinto
RIO
$164B
| $23K | ﹤0.01% |
+451
| New | +$24.6K |
|
567
Unilever
UL
$136B
| $23K | ﹤0.01% |
+365
| New | +$22.2K |
|
568
Vale
VALE
$62.6B
| $23K | ﹤0.01% |
+1,775
| New | +$23.4K |
|
|
NAV
569
DELISTED
Navistar International
NAV
| $23K | ﹤0.01% |
+653
| New | +$26.3K |
|
570
Baker Hughes
BKR
$61.1B
| $22K | ﹤0.01% |
+783
| New | +$23.9K |
|
|
VISN
571
Vistance Networks Inc
VISN
$2.52B
| $22K | ﹤0.01% |
+562
| New | +$21.9K |
|
|
SEE
572
DELISTED
Sealed Air
SEE
| $22K | ﹤0.01% |
+507
| New | +$22.9K |
|
573
Sanofi
SNY
$104B
| $22K | ﹤0.01% |
+541
| New | +$22.5K |
|
574
Thor Industries
THO
$4.14B
| $22K | ﹤0.01% |
+190
| New | +$25.4K |
|
575
UBS Group
UBS
$176B
| $22K | ﹤0.01% |
+1,220
| New | +$23.2K |
|
Similar funds
MWA
SFP
ECM
NRG
HW
LAM
BGIM
CIA
Convergence Investment Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Convergence Investment Partners held 1,093 positions worth $768M, up 3.1% from $745M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners deployed $26.3M of net new capital in Q1 2018, opening 800 new positions and adding to 114 existing holdings. Its largest new stake was CACI: 34,563 shares worth $5.23M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Teradata, an estimated $6.01M trimmed.
- Convergence Investment Partners's largest Q1 2018 buy was CACI: 34,563 shares worth $5.23M.
- Convergence Investment Partners added most to Pfizer in Q1 2018, an estimated $5.93M increase.
- Convergence Investment Partners's biggest Q1 2018 reduction was Teradata, cutting an estimated $6.01M.
- Convergence Investment Partners fully exited Ingevity in Q1 2018, selling an estimated $3.95M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $768M portfolio in Q1 2018.
- Convergence Investment Partners opened 800 new positions and closed 54 in Q1 2018.
- Convergence Investment Partners's portfolio value rose 3.1% quarter-over-quarter to $768M.
Based on Convergence Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.